TOP > R&D INFORMATION > Development Pipeline
R&D INFORMATION

Development Pipeline

Establishment of Top World-Class R&D Pipelines

As a part of our vision to be a Global Pharma Innovator, Daiichi Sankyo Group set a goal to challenge the unmet medical needs. To reinforce the competitiveness of research in the disease areas which have high unmet medical needs, we focus our resources on Oncology and cardiovascular-Metabolics as the priority areas in our solid foundation that has been built up over the years.

Primary Items for Development

Listing of the primary items for development:January, 2012

Listing of the primary items for development:January, 2012